WS7-24589-66203

2 vaccinations 3 coded responses 15 check-ins 3 free-text entries 8 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 950 / CA
Registered: 2021-01-07

Relationship: Self
Race: Asian
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-07
Registered in v-safe
2021-01-07
Dose 1 — Pfizer-BioNTech
2021-01-07
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Adult check-in
2021-01-08
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-01-09
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-10
Survey response — days 1–6 daily, dose 1
MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Free text: Swollen and tender axillary lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-10
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-11
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-11
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-12
Survey response — days 1–6 daily, dose 1
MedDRA: Decreased appetite — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Decrease appetite

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-13
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-13
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Health check-in — day 7, dose 1
Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-14
Report sent to call center — day 7, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-21
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-23
Dose 2 — Pfizer-BioNTech
2021-02-15
Call 1 — Could Not Reach Participant
2021-02-21
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-27
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-08
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-04-24
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2021-07-24
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-23
Survey response — 12 months, dose 2
MedDRA: Cough, Diarrhoea, Fatigue, Headache, Malaise, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Sore throat, cough, fever, diarrhea, vomiting, fatigue, malaise, runny nose, headache, body ache

MedDRA releases: 2024-11 · check-in free text available
2022-01-23
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-24
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-07	Pfizer-BioNTech
2	2021-01-23	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-08	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-01-09	Unsuccessful
2021-01-10	Unsuccessful
2021-01-11	Unsuccessful
2021-01-12	Unsuccessful
2021-01-13	Unsuccessful
2021-01-14	Unsuccessful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-01-23	Successful 2022-01-24	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-10

Systemic reaction (other): Swollen and tender axillary lymph nodes

2021-01-12

Systemic reaction (other): Decrease appetite

Release 11 — 12 months, dose 2

2022-01-23

Symptoms: Sore throat, cough, fever, diarrhea, vomiting, fatigue, malaise, runny nose, headache, body ache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Diarrhoea	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Malaise	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Vomiting	·	·	✓
SRO	Decreased appetite	✓	✓	✓
SRO	Lymph node pain	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release